| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/07/2008 | US20080188571 Oral controlled release intercalation formulation using such as aluminum lithium hydroxide derivative; reducing stomach upset by providing antiacid effect |
| 08/07/2008 | US20080188550 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents |
| 08/07/2008 | US20080188509 Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188469 Vaccination |
| 08/07/2008 | US20080188416 Easily alterable or removable implants; producing desired structural change; treating wrinkles, aging effects, scars; such as polymethyl methacrylate matrix material with chondroitin sulfate |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187968 For eukaryotic in vitro expression; silicone-based surfactants and microcapsules; phage display |
| 08/07/2008 | US20080187602 Stabilized lanthanum carbonate compositions |
| 08/07/2008 | US20080187596 Delivery efficiency; perfumes, silicones, waxes, flavors, vitamins, fabric softeners, cosmetics, laundering products; core with overcoating |
| 08/07/2008 | US20080187595 Method For Carrying Therapeutic Substances Into Cells |
| 08/07/2008 | US20080187594 Dosage Form With Improved Release Of Cefuroximaxetil |
| 08/07/2008 | US20080187593 Administering sophorolipids; antiallergens, atopic diseases; skin disorders; antiinflammatory agents; autoimmune diseases; multiple sclerosis |
| 08/07/2008 | US20080187592 Cosmetic Composition Comprising A Tensioning Agent And A Hydroxyalkyl Urea |
| 08/07/2008 | US20080187591 Rapidly acting dry sealant and methods for use and manufacture |
| 08/07/2008 | US20080187590 Containing entacapone; therapy for parkinson's disease |
| 08/07/2008 | US20080187589 Multi-modal delivery via transmucosal and gastro-intestinal absorption of antihistamines and symptom relief |
| 08/07/2008 | US20080187588 Containing phosphodiesterase inhibitor vardensfil; erectile dysfunction |
| 08/07/2008 | US20080187587 Multilayer capsules for sustained release ; therapy for sleep disorders |
| 08/07/2008 | US20080187586 Pharmaceutical Compositions for Glucocorticoid Replacement Therapy |
| 08/07/2008 | US20080187585 Side effect reduction of diuretic |
| 08/07/2008 | US20080187584 Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
| 08/07/2008 | US20080187583 Mixing with wetting agents; compression |
| 08/07/2008 | US20080187582 Solid dosage of water sensitive drug; oral administering; prevention, therapy for diseases mediated by lymphocytes; protein kinase inhibitor |
| 08/07/2008 | US20080187581 Solid dosage form; active materials and solid on substrate |
| 08/07/2008 | US20080187580 Using 1,3-oxathiolane compound; against hepatitis B viral infections |
| 08/07/2008 | US20080187579 Extended-release dosage form |
| 08/07/2008 | US20080187578 Platinum Aggregates and Process for Producing the Same |
| 08/07/2008 | US20080187577 Immunogenic compositions comprising progastrin and uses thereof |
| 08/07/2008 | US20080187576 Osteoarthritis; rheumatic diseases; gene therapy; interleukin receptor antagonist peptide or polypeptide |
| 08/07/2008 | US20080187575 Pyrimidine Derivatives |
| 08/07/2008 | US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component |
| 08/07/2008 | US20080187572 Administering compound which stabilizes cadherin |
| 08/07/2008 | US20080187561 Enteric Coated Didanosine Compositions Having A Subcoat |
| 08/07/2008 | US20080187560 Controlling biofilm on surface of rubber article |
| 08/07/2008 | US20080187558 High speed dissolving dosage form; administering to mucous membranes;matric containing gelating, starch nd mannitol |
| 08/07/2008 | US20080187553 Immunstimulating lipid formulation |
| 08/07/2008 | US20080187495 Copolymer from butyl(meth)acrylate monomers, hydroxy alkyl (meth)acrylate monomers, and optional co-polymerizable monomers |
| 08/07/2008 | US20080187487 Methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 08/07/2008 | US20080184618 Adsorbing, binding deactivated viruses; therap for mammals infections; gastrointestinal disorders |
| 08/07/2008 | DE102004055497B4 Wirkstoffkissen Drug pillows |
| 08/07/2008 | DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient |
| 08/07/2008 | CA2824842A1 Method for preparing particles comprising metal oxide coating and particles with metal oxide coating |
| 08/07/2008 | CA2677193A1 Tablet preparation without causing a tableting trouble |
| 08/07/2008 | CA2677184A1 Compositions for topical application comprising a peroxide and retinoid |
| 08/07/2008 | CA2677125A1 Drug substance preparations, pharmaceutical compositions and dosage forms |
| 08/07/2008 | CA2676986A1 Pharmaceutical composition comprising a campothecin derivative |
| 08/07/2008 | CA2676979A1 Compositions for aerosolization of highly conductive solutions |
| 08/07/2008 | CA2676919A1 Novel biomaterials for ocular drug delivery and a method for making and using same |
| 08/07/2008 | CA2676841A1 Controlled release of actives in skin |
| 08/07/2008 | CA2676803A1 Novel crystal of piperacillin sodium |
| 08/07/2008 | CA2676650A1 Extended-release dosage form |
| 08/07/2008 | CA2674913A1 Punctal plugs and methods of delivering therapeutic agents |
| 08/06/2008 | EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 08/06/2008 | EP1952825A1 Nanometer targeted drug for magneto-thermotherapy of malignant tumors |
| 08/06/2008 | EP1952818A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 08/06/2008 | EP1952810A1 Treatment of breast cancer with 4-hydroxytamoxifen |
| 08/06/2008 | EP1952809A2 Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen |
| 08/06/2008 | EP1952807A1 Sirolimus formulation |
| 08/06/2008 | EP1952806A1 Process for the preparation of adsorbates of candesartan |
| 08/06/2008 | EP1952805A1 Tablet containing hydrogenated phospholipids |
| 08/06/2008 | EP1952804A1 Injury treatment agent |
| 08/06/2008 | EP1952803A1 Solid pharmaceutical dosage form containing hydrogenated phospholipids |
| 08/06/2008 | EP1952802A2 Buccal, polar and non-polar spray or capsule |
| 08/06/2008 | EP1951762A1 Compositions and methods for improved skin care |
| 08/06/2008 | EP1951693A2 Solid formulations |
| 08/06/2008 | EP1951374A1 Treatment of sub-gingival pocket infections |
| 08/06/2008 | EP1951357A1 Microneedle arrays and methods of preparing same |
| 08/06/2008 | EP1951314A2 Drug-delivery systems |
| 08/06/2008 | EP1951267A2 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 08/06/2008 | EP1951258A2 Liquid formulations |
| 08/06/2008 | EP1951256A1 Quetiapine in a controlled release formulation |
| 08/06/2008 | EP1951248A2 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 08/06/2008 | EP1951245A2 Pharmaceutical compositions comprising methotrexate |
| 08/06/2008 | EP1951240A2 Pharmaceutical compositions comprising buprenorphine |
| 08/06/2008 | EP1951232A2 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 08/06/2008 | EP1951223A2 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations |
| 08/06/2008 | EP1951219A1 Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate |
| 08/06/2008 | EP1951211A1 Transdermal preparations containing hydrophobic non-steroidal anti-inflammatory drugs |
| 08/06/2008 | EP1951210A2 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 08/06/2008 | EP1951209A2 Multi-layered coating technology for taste masking |
| 08/06/2008 | EP1951208A2 Lipophilic vehicle-based dual controlled release matrix system as capsule fill |
| 08/06/2008 | EP1951207A2 Pharmaceutical composition |
| 08/06/2008 | EP1951206A1 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 08/06/2008 | EP1951205A2 Stable composition for a pharmaceutical formulation containing olanzapine |
| 08/06/2008 | EP1951204A2 Chemical preconditioning as a preventative or treatment for excitotoxic synaptic damage |
| 08/06/2008 | EP1951203A1 Intraorally rapidly disintegrating tablet |
| 08/06/2008 | EP1951202A2 Isolated and fixed micro and nano structures and methods thereof |
| 08/06/2008 | EP1951201A1 Non-irritating formulation and method for the intradermal delivery of substances |
| 08/06/2008 | EP1951200A2 Nanoemulsion compositions having anti-inflammatory activity |
| 08/06/2008 | EP1951199A2 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 08/06/2008 | EP1951198A2 Intranasal administration of rapid acting insulin |
| 08/06/2008 | EP1951197A1 Process to control particle size |
| 08/06/2008 | EP1951196A1 Tablets comprising a core and a medicament-containing coating for buccal release |
| 08/06/2008 | EP1951193A2 Silicone vesicles containing actives |
| 08/06/2008 | EP1874291B1 Use of zinc gluconate for treating hydradenitis suppurativa |
| 08/06/2008 | EP1850670A4 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof |
| 08/06/2008 | EP1744789B1 X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses |
| 08/06/2008 | EP1725217B1 Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride |
| 08/06/2008 | EP1635802B1 Method for inhibiting the growth of antibiotic-resistant bacteria by using pentane-1,5-diol |